| 12801411 | Schws8 | Schwannoma susceptibility QTL 8 | | | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 94968928 | 139968928 | Rat |
| 1331797 | Bp213 | Blood pressure QTL 213 | 3.291 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 6 | 104085867 | 128713626 | Rat |
| 1331799 | Bp211 | Blood pressure QTL 211 | 3.66407 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 6 | 72202632 | 130919985 | Rat |
| 1358355 | Srcrt4 | Stress Responsive Cort QTL 4 | 6.39 | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 6 | 100364669 | 140994061 | Rat |
| 2313399 | Anxrr28 | Anxiety related response QTL 28 | | | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 6 | 100671796 | 132340886 | Rat |
| 1331789 | Rf37 | Renal function QTL 37 | 3.224 | | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 6 | 72202632 | 115200186 | Rat |
| 1331725 | Bp212 | Blood pressure QTL 212 | 3.52475 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 6 | 93701310 | 128713626 | Rat |
| 1331722 | Thshl1 | Thyroid stimulating hormone level QTL 1 | 11.7 | 0.0001 | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 6 | 89762877 | 106752806 | Rat |
| 8552796 | Vie3 | Viral induced encephalitis QTL 3 | 2.6 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 6 | 96833997 | 140994061 | Rat |
| 4145119 | Mcs25 | Mammary carcinoma susceptibility QTL 25 | | 0.0001 | mammary gland integrity trait (VT:0010552) | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 10894415 | 110548006 | Rat |
| 1581563 | Uae33 | Urinary albumin excretion QTL 33 | | | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 72227641 | 130729205 | Rat |
| 10054138 | Gmadr3 | Adrenal mass QTL 3 | 3.68 | 0.00045 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 6 | 85140138 | 130140138 | Rat |
| 61414 | Pia3 | Pristane induced arthritis QTL 3 | 4.5 | | joint integrity trait (VT:0010548) | post-insult time to onset of experimental arthritis (CMO:0001450) | 6 | 94968928 | 137848904 | Rat |
| 724524 | Uae2 | Urinary albumin excretion QTL 2 | 2.7 | 0.0005 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 73463459 | 109394713 | Rat |
| 737827 | Hcar11 | Hepatocarcinoma resistance QTL 11 | 4.4 | | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 6 | 82523650 | 110548006 | Rat |
| 1641904 | Alcrsp4 | Alcohol response QTL 4 | | | response to alcohol trait (VT:0010489) | duration of loss of righting reflex (CMO:0002289) | 6 | 67262953 | 112262953 | Rat |
| 724513 | Uae14 | Urinary albumin excretion QTL 14 | 6.5 | | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 85311061 | 133478515 | Rat |
| 2303624 | Vencon5 | Ventilatory control QTL 5 | 4.45 | | respiration trait (VT:0001943) | minute ventilation (CMO:0000132) | 6 | 88047916 | 133047916 | Rat |
| 1576309 | Emca7 | Estrogen-induced mammary cancer QTL 7 | 4 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 15107216 | 107351382 | Rat |
| 731173 | Uae22 | Urinary albumin excretion QTL 22 | 10.1 | | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 65531555 | 140994061 | Rat |
| 10054123 | Srcrt6 | Stress Responsive Cort QTL 6 | 2.5 | 0.0043 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 6 | 85140138 | 130140138 | Rat |
| 724536 | Uae7 | Urinary albumin excretion QTL 7 | 3.5 | | urine albumin amount (VT:0002871) | urine albumin level (CMO:0000130) | 6 | 72202632 | 130729475 | Rat |
| 70196 | BpQTLcluster7 | Blood pressure QTL cluster 7 | 6.82 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 72202632 | 117202632 | Rat |
| 1581550 | Pur8 | Proteinuria QTL 8 | | | urine total protein amount (VT:0000032) | urine total protein excretion rate (CMO:0000756) | 6 | 72227641 | 130729205 | Rat |
| 1576302 | Schws4 | Schwannoma susceptibility QTL 4 | | 0.0078 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 83190345 | 106747639 | Rat |
| 1300075 | Glom7 | Glomerulus QTL 7 | 5.6 | 0.0000002 | kidney glomerulus morphology trait (VT:0005325) | count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002) | 6 | 71201409 | 116201409 | Rat |
| 738034 | Anxrr5 | Anxiety related response QTL 5 | 5.9 | | exploratory behavior trait (VT:0010471) | percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) | 6 | 84130881 | 129130881 | Rat |
| 2290393 | Uae37 | Urinary albumin excretion QTL 37 | | 0.0001 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 65531555 | 140994061 | Rat |
| 12801471 | Schws9 | Schwannoma susceptibility QTL 9 | | | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 61747639 | 106747639 | Rat |
| 1300076 | Glom8 | Glomerulus QTL 8 | 7 | 9e-09 | kidney glomerulus morphology trait (VT:0005325) | count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) | 6 | 86894788 | 131894788 | Rat |
